サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439692

内視鏡 - 世界市場の考察、競合情勢、市場予測（2030年）

Endoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
内視鏡 - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の内視鏡の市場規模は、2023年に129億5,000万米ドル、2030年までに183億2,000万米ドルに達し、2024年～2030年の予測期間にCAGRで6.05％の成長が見込まれます。内視鏡需要の増加は主に、過敏性腸症候群（IBD）、胃食道逆流症（GERD）、消化性潰瘍疾患、クローン病などの消化器疾患などの診断に内視鏡の使用を必要とする慢性疾患の有病率の増加や、慢性疾患にかかりやすい老年人口の増加、低侵襲手術や無血手術の認知度や需要の増加によるものであり、画像倍率、高精細光学システム、デジタルイメージングのような内視鏡の技術の進歩が市場を強化し、2024年～2030年の予測期間に内視鏡市場の成長に寄与すると見込まれます。

内視鏡の市場力学

内視鏡市場は、さまざまな理由により製品需要が伸びています。さまざまな用途における内視鏡の使用の増加が、予測期間に内視鏡市場を強化する見込みです。

内視鏡は、環境汚染、喫煙、不健康な生活習慣、不十分な栄養や食事、発がん性物質の多量摂取などが原因で、IBD、胃食道逆流症（GERD）、消化性潰瘍、クローン病などの慢性疾患の有病率が増加しているため、さまざまな応用分野で使用されています。

米国疾病予防管理センター（CDC）の2022年の発表によると、2020年に消化管潰瘍と診断された成人の数は1,480万人と推定されています。胃腸潰瘍には消化性潰瘍、食道潰瘍、潰瘍性大腸炎などが含まれます。米国がん協会（American Cancer Society）（2022）によると、過去1年間に新たに診断された食道がんは約2万640例で、男性が1万6,510例、女性が4,130例と推定されています。食道がんの診断は上部消化管内視鏡検査によって行われます。食道がんの有病率は高く、内視鏡市場を後押ししています。

予測期間の市場に影響を与えるもう1つの要因は、老年人口の増加です。WHOによると、2019年の60歳以上の人口は10億人でした。この数は2030年までに14億人、2050年までに21億人に増加すると予測されています。この増加はかつてないペースで起こっており、特に発展途上国では今後数十年で加速すると予測されています。慢性疾患やがんに罹患する可能性は高齢になるほど高くなるため、老年人口が増加するにつれて、老年人口における慢性疾患の有病率が増加する可能性が高まり、市場における製品需要が増加します。

また、低侵襲手術や無血手術に対する認識や需要の高まりは、内視鏡市場を強化します。

したがって、さまざまな応用分野における内視鏡の利用の増加により、内視鏡の需要が増加し、内視鏡市場の成長を増加させる見込みです。

しかし、先進の内視鏡の取り扱いにおける問題や、農村部や発展途上地域における内視鏡の操作に関する知識の不足、新世代の器具の高いコストが、内視鏡市場の成長の一致の抑制要因となる可能性があります。

進行中のCOVID-19パンデミックは内視鏡市場に若干の影響を与えています。疾患の発生当初は、ウイルスの蔓延を抑えるために厳重なロックダウンが行われたため、かなりの品薄状態でした。がんやその他の慢性疾患の患者の入院は、COVID-19患者に比べて低い優先順位にありました。一部の医療機器の生産は停止されました。さらに、パンデミック中、手術は一時的に中止されました。COVID-19の感染リスクを減らすために、内視鏡センターは準緊急症例や選択的症例を延期したりキャンセルしたりしました。しかし、多くの人々がワクチン接種を受けたことで、内視鏡市場は勢いを取り戻しています。

内視鏡市場のセグメント分析

内視鏡市場の用途タイプセグメントでは、消化器内視鏡が予測期間（2024年～2030年）において大きなシェアを占める見込みです。これは、これらのデバイスに関連するさまざまな利点によるものと考えられます。

当レポートでは、世界の内視鏡市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 内視鏡市場レポートのイントロダクション

第2章 内視鏡市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 内視鏡市場の主な要因の分析

  • 内視鏡市場の促進要因
    • 慢性疾患の有病率の増加
    • 過敏性腸症候群（IBD）や胃食道逆流症（GERD）などの消化器疾患のような慢性疾患の早期診断における利用の増加
    • 慢性疾患にかかりやすい老年人口の増加
    • 低侵襲手術と無血手術に対する意識と需要の高まり
    • 内視鏡における画像倍率、高精細光学システム、デジタルイメージングなどの技術の進歩
  • 内視鏡市場の抑制要因と課題
    • 内視鏡の高いコスト
    • 先進の機器の操作に関する知識の不足
  • 内視鏡市場の機会
    • ロボット内視鏡と使い捨て内視鏡の進歩
    • 低開発国市場の開発

第5章 内視鏡市場のポーターのファイブフォース分析

第6章 内視鏡市場に対するCOVID-19の影響分析

第7章 内視鏡市場のレイアウト

  • 柔軟性タイプ別
    • 軟質
    • 硬質
  • 使い捨てタイプ別
    • 使い捨て
    • 再使用可能
  • 製品タイプ別
    • 従来式
    • 非従来式
  • 用途タイプ別
    • 胃腸
    • 耳鼻咽喉科
    • 腫瘍
    • 呼吸器
    • 婦人科
    • 泌尿器科
    • その他
  • エンドユーザー別
    • 病院、診療所
    • 外来手術センター
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 内視鏡市場：世界の企業シェア分析 - 主要3～5社

第9章 内視鏡市場の企業と製品のプロファイル

  • Boston Scientific Corporation
  • CONMED Corporation
  • OLYMPUS CORPORATION
  • PENTAX Medical
  • FUJIFILM Holdings America Corporation
  • Stryker.
  • Karl Storz GmbH & Co., KG
  • Richard Wolf GmbH.
  • Medtronic
  • Machida Endoscope Co., Ltd
  • Pro Scope Systems
  • Laborie.
  • AED.MD
  • EMED
  • Happersberger otofront GmbH
  • Optomic.
  • EMOS Technology GmbH
  • Delmont imaging
  • Luxamed - Medical technology
  • Hangzhou Kangji Medical Instrument Co., Ltd
  • Daichuan medical

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Endoscopes Market in Global (2021-2030)
  • Table 4: Endoscopes Market in Global by Product Type (2021-2030)
  • Table 5: Endoscopes Market in Global by Application Type (2021-2030)
  • Table 6: Endoscopes Market in Global by End User (2021-2030)
  • Table 7: Endoscopes Market in Global by Geography (2021-2030)
  • Table 8: Endoscopes Market in North America (2021-2030)
  • Table 9: Endoscopes Market in North America by Country (2021-2030)
  • Table 10: Endoscopes Market in the US (2021-2030)
  • Table 11: Endoscopes Market in Canada (2021-2030)
  • Table 12: Endoscopes Market in Mexico (2021-2030)
  • Table 13: Endoscopes Market in Europe (2021-2030)
  • Table 14: Endoscopes Market in Europe by Country (2021-2030)
  • Table 15: Endoscopes Market in France (2021-2030)
  • Table 16: Endoscopes Market in Germany (2021-2030)
  • Table 17: Endoscopes Market in the United Kingdom (2021-2030)
  • Table 18: Endoscopes Market in Italy (2021-2030)
  • Table 19: Endoscopes Market in Spain (2021-2030)
  • Table 20: Endoscopes Market in Russia (2021-2030)
  • Table 21: Endoscopes Market in Rest of Europe (2021-2030)
  • Table 22: Endoscopes Market in APAC (2021-2030)
  • Table 23: Endoscopes Market in APAC by Country (2021-2030)
  • Table 24: Endoscopes Market in China (2021-2030)
  • Table 25: Endoscopes Market in Japan (2021-2030)
  • Table 26: Endoscopes Market in India (2021-2030)
  • Table 27: Endoscopes Market in Australia (2021-2030)
  • Table 28: Endoscopes Market in South Korea (2021-2030)
  • Table 29: Endoscopes Market in Rest of APAC (2021-2030)
  • Table 30: Endoscopes Market in Rest of World (2021-2030)
  • Table 31: Endoscopes Market in RoW by Region (2021-2030)
  • Table 32: Endoscopes Market in Middle East (2021-2030)
  • Table 33: Endoscopes Market in Africa (2021-2030)
  • Table 34: Endoscopes Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Endoscopes Market in Global (2021-2030)
  • Figure 4: Endoscopes Market in Global by Product Type (2021-2030)
  • Figure 5: Endoscopes Market in Global by Application Type (2021-2030)
  • Figure 6: Endoscopes Market in Global by End User (2021-2030)
  • Figure 7: Endoscopes Market in Global by Geography (2021-2030)
  • Figure 8: Endoscopes Market in North America (2021-2030)
  • Figure 9: Endoscopes Market in North America by Country (2021-2030)
  • Figure 10: Endoscopes Market in the US (2021-2030)
  • Figure 11: Endoscopes Market in Canada (2021-2030)
  • Figure 12: Endoscopes Market in Mexico (2021-2030)
  • Figure 13: Endoscopes Market in Europe (2021-2030)
  • Figure 14: Endoscopes Market in Europe by Country (2021-2030)
  • Figure 15: Endoscopes Market in France (2021-2030)
  • Figure 16: Endoscopes Market in Germany (2021-2030)
  • Figure 17: Endoscopes Market in the United Kingdom (2021-2030)
  • Figure 18: Endoscopes Market in Italy (2021-2030)
  • Figure 19: Endoscopes Market in Spain (2021-2030)
  • Figure 20: Endoscopes Market in Russia (2021-2030)
  • Figure 21: Endoscopes Market in Rest of Europe (2021-2030)
  • Figure 22: Endoscopes Market in APAC (2021-2030)
  • Figure 23: Endoscopes Market in APAC by Country (2021-2030)
  • Figure 24: Endoscopes Market in China (2021-2030)
  • Figure 25: Endoscopes Market in Japan (2021-2030)
  • Figure 26: Endoscopes Market in India (2021-2030)
  • Figure 27: Endoscopes Market in Australia (2021-2030)
  • Figure 28: Endoscopes Market in South Korea (2021-2030)
  • Figure 29: Endoscopes Market in Rest of APAC (2021-2030)
  • Figure 30: Endoscopes Market in Rest of World (2021-2030)
  • Figure 31: Endoscopes Market in RoW by Region (2021-2030)
  • Figure 32: Endoscopes Market in Middle East (2021-2030)
  • Figure 33: Endoscopes Market in Africa (2021-2030)
  • Figure 34: Endoscopes Market in South America (2021-2030)
  • Figure 35: Market Drivers
  • Figure 36: Market Barriers
  • Figure 37: Marker Opportunities
  • Figure 38: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0534

Endoscopes Market By Flexibity Type (Flexible And Rigid), By Disposability Type (Disposable And Reusable), By Product Type (Coventional [Bronchoscopes, Duedonescopes, Colonscopes, Cystoscopes, Rhinoscopes, And Others] And Non-Conventional [Capsule Endoscopes And Robort-Assisted Endoscopes]), By Application Type (Gastrointestinal, Ent, Oncology, Respiratory, Gynacology, Urology And Others), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers And Other), by geography is expected to grow at a steady cagr forecast till 2030 owing to increased prevalence of chronic diseases which require endoscopes for diagnosis and increased in early diagnosis and treatment of various cancers and some chronic diseases

Global endoscopes market was valued at USD 12.95 billion in 2023, growing at a CAGR of 6.05% during the forecast period from 2024 to 2030 to reach USD 18.32 billion by 2030. The increase in demand for endoscopes is primarily attributed to the increasing prevalence of chronic disease which require the use of endoscopes for diagnosis, such as some gastrointestinal diseases like irritable bowel syndrome (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn's disease, increase in number of geriatric population who are more prone to chronic ailments, increasing awareness and demand of minimally invasive surgeries and no blood loss surgery, and rise in technological advancements in endoscopes like image magnification, high-definition optical systems and digital imaging are anticipated to bolster the market, thereby contributing to the growth of the endoscopes market during the forecast period from 2024-2030.

Endoscopes Market Dynamics:

The endoscopes market is witnessing a growth in product demand owing to various reasons. The increasing use of endoscopes in various applications is anticipated to bolster the market for endoscopes during the forecasted period.

Endoscopes had found their use in various areas of application attributed to increasing prevalence of chronic disorders like IBD, gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn's disease due to environmental pollution, smoking, unhealthy lifestyles, poor nutrition and diet, and high intake of carcinogenic substances.

According to Centers for Disease Control and Prevention (CDC) 2022, estimated that the number of adults with diagnosed gastrointestinal ulcers was 14.8 million in 2020. Gastorintetinal ulcers includes peptic ulcers, esophageal ulcer, ulcerative colitis and many more. According to American Cancer Society 2022, it was estimated that about 20,640 new esophageal cancer cases were diagnosed with 16,510 in men and 4,130 in women in past year. The diagnosis of esophageal cancer is done by upper endoscopy. The prevalence of esophageal cancer is higher, owing to propel the market of endoscopes.

Another factor which will affect the market in forecasting period is increasing number of geriatric population. According to WHO, in 2019, the number of people aged 60 years and older was 1 billion. This number is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. This increase is occurring at an unprecedented pace and is expected to accelerate in coming decades, particularly in developing countries. The possibility of having a chronic disorder or cancer is higher in the older age, so as the number of geriatric population is increasing, this will increase the probability of increasing prevalence of a chronic ailment in geriatric population thereby owing to increase the product demand in the market.

Also, the increaseing awareness and demand of minimally invasive surgery and of no or less blood surgery will bolster the market of endoscopes.

Thus, due to the increasing utilization of endoscopes in various areas of application, there will be a rising demand for endoscopes, in turn increasing the endoscopes market growth.

However, problems in handling of the advanced endoscopes, less knowledge about operating the endoscopes in rural or under-developing area and high cost of new generation instruments may be certain limiting factors of the endoscopes market growth.

The ongoing COVID-19 pandemic has slightly impacted the market for endoscopes. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from cancers and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some medical devices was shutdown. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, endoscopy centers have postponed and canceled the semi-urgent and elective cases. However, with masses being vaccinated, the endoscopes market has picked momentum.

Endoscopes Market Segment Analysis:

Endoscopes Market by Flexibity Type (Flexible and Rigid), by Disposability Type (Disposable and Reusable), by Product Type (Coventional [Bronchoscopes, Duedonescopes, Colonscopes, Cystoscopes, Rhinoscopes, and Others] And Non-Conventional [Capsule Endoscopes and Robort-Assisted Endoscopes]), by Application Type (Gastrointestinal, ENT, Oncology, Respiratory, Gynacology, Urology and Others), by End-User (Hospitals And Clinics, Ambulatory Surgical Centers and Other) and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Application Type segment of the Endoscopes market, the Gastrointestinal endoscopy are estimated to hold a significant share in the Endoscopes market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices.

The demand for gastrointestinal endoscopes is expected to increase during the forecast period. This is owing to the rising prevalence of chronic disease such as inflammatory bowel disease (IBD), which is a group of disorder accompanied with chronic inflammation - pain and swelling - in intestine. IBD includes Crohn's disease and ulcerative colitis. According to Centers for Disease Control and Prevention (CDC) in 2022, a study concluded that the prevalence of IBD increased from 2001 to 2018 among all race and ethnicity groups, with a higher increase rate among non-Hispanic Black adults. It is estimated that the prevalence of IBD among U.S. population will rise to around 3.5 million by 2030, accounting for market growth of endoscopes.

Endoscopes also comprise technological advancements that enable the long and thin tube of endoscopes to enter the body through natural opening like mouth or by minimal by producing minimal cut in the body. These advancements increases the application of early diagnosis and treatment. According to Crohn's and Colitis Canada, 300,000 Canadians are having IBD. By 2030, the number of Canadians with IBD is expected to rise to 400,000 (approximately 1% of the population). Peope with age 65 years or above are calculated as the fastest growing group of Canadians with IBD. As per the same source, there are over 7,000 Canadian children - under age 18 - living with Crohn's or colitis. The prevalence of the above disorders can be controlled by encouraging and implementing the early diagnosis of these chronic disorders using endoscopes, thereby bolstering the market of endoscopes.

Thus, owing to the technological advancements in the area of endoscopes, there will be an increase in the demand for gastrointestinal endoscopes, which in turn will drive the endoscopes market growth.

North America is expected to dominate the overall Endoscopes Market:

Among all the regions, North America is expected to account for the largest share in the global Endoscopes market. Growing incidence of chronic diseases such as cancer, kidney disease, crohn's disease, improved healthcare expenditure, and the high geriatric population will increase the demand for endoscopes in North America, leading to a rise in the overall endoscopes market growth.

For instance, as per the National Cancer Institute 2020, an estimated number of 1,806,590 new cases of cancer were diagnosed in the United States and about 606,520 patients died from the disease. Also, as per the American Cancer Society 2020, 1.9 million new cancer cases were diagnosed. Moreover, according to CDC 2022, number of adults with diagnosed digestive ulcers were 14.8 million.

According to American Cancer Society's publication, Cancer Facts & Figures 2022, estimated that 20,640 adults were diagnosed with esophageal cancer in 2020. As the prevalence of cancers and digestive cancers and other GIT ailments like GERD, peptic ulcer and esophageal ulcer is increasing, this will increase the demand of endoscopes in the diagnosistic field thereby propelling the market of endoscopes in the North America.

Another driving factor for endoscope market will be the increasing number of geriatric population. According to Government of Canada 2022, by 2030 seniors are expected to over 9.5 million and make up 23% of Canadians. Moreover, as per the same source, by 2036, the average life expectancy at birth for women will rise to 86.2 years from the current 84.2 and to 82.9 years from the current 80 for men. Geriatric patients are more suseptable to cancer and chronic ailments owing to the increased diagnosis rate of these disorders. As the number of geriatric people is expected to increase in the forecast period a rise in demand of endosocopes in the market is seen in the forecast period in the region.

Thus, all the above-mentioned factors are anticipated to propel the market for Endoscopes in the North America.

Endoscopes Market Key Players:

Some of the key market players operating in the Endoscopes market include Boston Scientific Corporation, CONMED Corporation, OLYMPUS CORPORATION, PENTAX Medical, FUJIFILM Holdings America Corporation, Stryker., Karl Storz GmbH & Co., KG, Richard Wolf GmbH., Medtronic, Machida Endoscope Co., Ltd, Pro Scope Systems, Laborie., AED.MD, EMED, Happersberger otofront GmbH, Optomic., EMOS Technology GmbH, Delmont imaging, Luxamed - Medical technology, Hangzhou Kangji Medical Instrument Co.,Ltd., Daichuan medical, among others.

Recent Developmental Activities in the Endoscopes Market:

In March 2022, Shenzhen Xzing Technology Co. Ltd.'s was granted the National Medical Products Administration (NMPA's) class II approval for Endofresh disposable upper gastrointestinal (GI) endoscope. The approved product will be used for upper gastrointestinal GI endoscopy, diagnosis and treatment.

In November 2022, Medtronic plc announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its PillCam (Capsule endoscope) for remote endoscopy procedures.

In March 2019, Cook Medical and Ambu A/S entered into a partnership under which Cook will distribute Ambu's single-use, disposable duodenoscope in the U.S.

Key Takeaways from the Endoscopes Market Report Study

  • Market size analysis for current endoscopes market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Endoscopes market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global endoscopes market.
  • Various opportunities available for the other competitor in the endoscopes market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current endoscopes market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for endoscopes market growth in the coming future?

Target Audience who can be benefited from this Endoscopes Market Report Study

  • Endoscopes products providers
  • Research organizations and consulting companies
  • Endoscopes-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in endoscopes
  • Various End-users who want to know more about the endoscopes market and latest technological developments in the endoscopes market.

Frequently Asked Questions for Endoscopes Market:

1. What are Endoscopes?

Endoscopy is a medical procedure that is used to observe the inside of the body without performing major surgery. An endoscope is a long flexible tube with a lens at one end and a video camera at the other. The end with the lens is inserted into the patient. It is usually inserted through one of the body's natural openings, such as the mouth, urethra, or anus.

2. What is the market for Global Endoscopes?

Global endoscopes market was valued at USD 12.95 billion in 2023, growing at a CAGR of 6.05% during the forecast period from 2024 to 2030 to reach USD 18.32 billion by 2030.

3. What are the drivers for the Global Endoscopes Market?

The Endoscopes market is witnessing a positive market growth owing to the increasinged prevalence of chronic disease such as irritable bowel syndrome (IBD), gastroesophageal reflux disease (GERD), peptic ulcer disease, and crohn's disease, increase in number of prevalence of geriatric patient, increasinged awareness and demand of minimally invasive surgeries and no blood loss surgery for the treatment of chronic diseases, and rise in technological advancements in endoscopes like image magnification, high-definition optical systems and digital imaging across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Endoscopes Market?

Some of the key market players operating in the Endoscopes market include Boston Scientific Corporation, CONMED Corporation, OLYMPUS CORPORATION, PENTAX Medical, FUJIFILM Holdings America Corporation, Stryker., Karl Storz GmbH & Co., KG, Richard Wolf GmbH., Medtronic, Machida Endoscope Co., Ltd, Pro Scope Systems, Laborie., AED.MD, EMED, Happersberger otofront GmbH, Optomic., EMOS Technology GmbH, Delmont imaging, Luxamed - Medical technology, Hangzhou Kangji Medical Instrument Co.,Ltd., Daichuan medical and others.

5. Which region has the highest share in Endoscopes Market?

North America is expected to hold the highest share in the revenue in the Endoscopes market during the forecast period. Growing incidence of chronic diseases such as cancer, kidney disease, crohn's disease, improved healthcare expenditure, and the high geriatric population will increase the demand for endoscopes in North America, leading to a rise in the overall endoscopes market growth in this region.

Table of Contents

1.Endoscopes Market Report Introduction

2.Endoscopes Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Endoscopes Market Key Factors Analysis

  • 4.1. Endoscopes Market Drivers
    • 4.1.1. Increasing Prevalence of Chronic Disease
    • 4.1.2. Increased Application in Early Diagnosis of Chronic Diseases like in some Gastrointestinal Diseases such as Irritable Bowel Syndrome (IBD) and Gastroesophageal Reflux Disease (GERD)
    • 4.1.3. Increase in the Number of Geriatric Population which are more prone to Chronic Ailements
    • 4.1.4. Increasing Awareness and Demand of Minimally Invasive Surgeries and No Blood Loss Surgery
    • 4.1.5. Rise in Technological Advancements like Image Magnification, High-Definition Optical Systems and Digital Imaging in Endoscopes
  • 4.2. Endoscopes Market Restraints and Challenges
    • 4.2.1. High Cost of Endoscopes
    • 4.2.2. Less Knowledge About Operating the advanced Instruments
  • 4.3. Endoscopes Market Opportunities
    • 4.3.1. Advancements in Robotic and Disposable Endoscopes
    • 4.3.2. Tapping the Underdeveloped Nation Market

5. Endoscopes Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Endoscopes Market

7. Endoscopes Market Layout

  • 7.1. By Flexibity Type
    • 7.1.1. Flexible
    • 7.1.2. Rigid
  • 7.2. By Disposability Type
    • 7.2.1. Disposable
    • 7.2.2. Reusable
  • 7.3. By Product Type
    • 7.3.1. Coventional
      • 7.3.1.1. Bronchoscopes
      • 7.3.1.2. Duedonescopes
      • 7.3.1.3. Colonscopes
      • 7.3.1.4. Cystoscopes
      • 7.3.1.5. Rhinoscopes
      • 7.3.1.6. Others
    • 7.3.2 Non-conventional
      • 7.3.2.1. Capsule endoscopes
      • 7.3.2.2. Robort-assisted endoscopes
  • 7.4. By Application Type
    • 7.4.1. Gastrointestinal
    • 7.4.2. ENT
    • 7.4.3. Oncology
    • 7.4.4. Respiratory
    • 7.4.5. Gynacology
    • 7.4.6. Urology
    • 7.4.7. Others
  • 7.5. By End User
    • 7.5.1. Hospitals and Clinics
    • 7.5.2. Ambulatory Surgical Centers
    • 7.5.3. Others
  • 7.6. By Geography
    • 7.6.1. North America
      • 7.6.1.1. North America Endoscopes Market, by Country
      • 7.6.1.1.1. United States
      • 7.6.1.1.2. Canada
      • 7.6.1.1.3. Mexico
    • 7.6.2. Europe
      • 7.6.2.1. Europe Endoscopes Market, by Country
      • 7.6.2.1.1. France
      • 7.6.2.1.2. Germany
      • 7.6.2.1.3. United Kingdom
      • 7.6.2.1.4. Italy
      • 7.6.2.1.5. Spain
      • 7.6.2.1.6. Russia
      • 7.6.2.1.7. Rest of Europe
    • 7.6.3. Asia-Pacific
      • 7.6.3.1. Asia-Pacific Endoscopes Market, by Country
      • 7.6.3.1.1. China
      • 7.6.3.1.2. Japan
      • 7.6.3.1.3. India
      • 7.6.3.1.4. Australia
      • 7.6.3.1.5. South Korea
      • 7.6.3.1.6. Rest of Asia Pacific
    • 7.6.4. Rest of the World (RoW)
      • 7.6.4.1. RoW Endoscopes Market, by Region
      • 7.6.4.1.1. Middle East
      • 7.6.4.1.2. Africa
      • 7.6.4.1.3. South America

8. Endoscopes MARKET Global Company Share Analysis - Key 3-5 Companies

9. Endoscopes Market Company and Product Profiles

  • 9.1. Boston Scientific Corporation
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. CONMED Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. OLYMPUS CORPORATION
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. PENTAX Medical
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. FUJIFILM Holdings America Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Stryker.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. Karl Storz GmbH & Co., KG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Richard Wolf GmbH.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Medtronic
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Machida Endoscope Co., Ltd
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Pro Scope Systems
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Laborie.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. AED.MD
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. EMED
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. Happersberger otofront GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Optomic.
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. EMOS Technology GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. Delmont imaging
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy
  • 9.19. Luxamed - Medical technology
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4. Product Listing
    • 9.19.5. Entropy
  • 9.20. Hangzhou Kangji Medical Instrument Co., Ltd
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4. Product Listing
    • 9.20.5. Entropy
  • 9.21. Daichuan medical
    • 9.21.1. Company Overview
    • 9.21.2. Company Snapshot
    • 9.21.3. Financial Overview
    • 9.21.4. Product Listing
    • 9.21.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us